Skip to main content
Presentation
A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients
Pharmacy and Nursing Student Research and Evidence-Based Medicine Poster Session
  • Marissa Cushing, Cedarville University
  • Juanita A. Draime, Cedarville University
  • Bao-Ngoc Ho, Cedarville University
  • Jordan Nicholls, Cedarville University
  • Bethany Sibbitt, Cedarville University
  • Rebecca Widder, Cedarville University
  • Rebecca J. Gryka, Cedarville University
  • Denise S. Simpson, Cedarville University
Document Type
Poster Session
Publication Date
11-1-2012
Research Advisor(s)
Rebecca J. Gryka, Pharm.D., Ph.D.; Denise Simpson, Ph.D.
Keywords
  • Meropenem,
  • nausea,
  • pediatrics,
  • cystic fibrosis
Abstract
Cystic Fibrosis (CF) is a genetic disease, leading to changes of membrane secretions causing obstruction of smaller airways. CF patients often develop pulmonary infections and require antibiotic treatment. Meropenem is a broad spectrum beta lactam that acts by lysing microbes through interfering with bacterial cell wall synthesis. Although a safe and effective treatment, data on pediatric patients is limited.
Creative Commons License
Creative Commons Attribution-Noncommercial-No Derivative Works 3.0
Citation Information
Marissa Cushing, Juanita A. Draime, Bao-Ngoc Ho, Jordan Nicholls, et al.. "A Comparison of the Effect of Intermittent and Continuous Infusion of Meropenem on the Prevalence of Nausea in Pediatric Cystic Fibrosis Patients" (2012)
Available at: http://works.bepress.com/juanita-draime/2/